A detailed history of Two Sigma Securities, LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Two Sigma Securities, LLC holds 1,359 shares of UTHR stock, worth $427,487. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,359
Previous 1,087 25.02%
Holding current value
$427,487
Previous $239,000 30.54%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$210.76 - $249.51 $57,326 - $67,866
272 Added 25.02%
1,359 $312,000
Q4 2023

Feb 14, 2024

SELL
$214.88 - $256.94 $16,545 - $19,784
-77 Reduced 6.62%
1,087 $239,000
Q3 2023

Nov 14, 2023

BUY
$211.82 - $248.24 $246,558 - $288,951
1,164 New
1,164 $262,000
Q1 2023

May 15, 2023

BUY
$212.99 - $276.17 $223,000 - $289,149
1,047 Added 142.64%
1,781 $398,000
Q4 2022

Feb 14, 2023

BUY
$205.95 - $280.43 $151,167 - $205,835
734 New
734 $204,000
Q2 2022

Aug 15, 2022

BUY
$174.81 - $241.14 $548,029 - $755,973
3,135 New
3,135 $739,000
Q4 2021

Feb 14, 2022

SELL
$184.32 - $216.08 $216,391 - $253,677
-1,174 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$179.86 - $214.88 $211,155 - $252,269
1,174 New
1,174 $217,000
Q2 2019

Aug 14, 2019

SELL
$76.06 - $120.81 $178,664 - $283,782
-2,349 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$107.15 - $126.84 $251,695 - $297,947
2,349 New
2,349 $276,000
Q4 2018

Feb 14, 2019

SELL
$101.4 - $128.73 $167,411 - $212,533
-1,651 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$113.81 - $129.46 $187,900 - $213,738
1,651 New
1,651 $211,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $14.3B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.